About KBI Biopharma
KBI Biopharma is a company based in Durham (United States) founded in 1996 was acquired by JSR Life Sciences in February 2015.. KBI Biopharma has raised $18.29 million across 5 funding rounds from investors including NCBiotech, Ballast Point Ventures and INCJ. The company has 1,243 employees as of December 31, 2021. KBI Biopharma has completed 1 acquisition, including Alliance Protein Laboratories. KBI Biopharma offers products and services including Cell Line Development, Process Development, Analytical Development, Formulation Development, and Clinical Manufacturing. KBI Biopharma operates in a competitive market with competitors including Aldevron, Kemwell Biopharma, Eurogentec, Ovagen and Laurus Bio, among others.
- Headquarter Durham, United States
- Employees 1243 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
$31.68 K (USD)6as on Dec 31, 2023
-
Net Profit
$-7.46 K (USD)-203as on Dec 31, 2023
-
EBITDA
-
Total Equity Funding
$18.29 M (USD)
in 5 rounds
-
Latest Funding Round
$9.6 M (USD), Series A
Aug 14, 2009
-
Investors
NCBiotech
& 4 more
-
Employee Count
1243
as on Dec 31, 2021
- Investments & Acquisitions
-
Acquired by
JSR Life Sciences
(Feb 26, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of KBI Biopharma
KBI Biopharma offers a comprehensive portfolio of products and services, including Cell Line Development, Process Development, Analytical Development, Formulation Development, and Clinical Manufacturing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Development of cell lines for biopharmaceutical production processes
Creation of scalable processes for new biologic therapeutics
Comprehensive analysis and characterization of biologic molecules
Optimization of formulations for biologic stability and efficacy
GMP manufacturing for clinical-stage biopharmaceuticals
Unlock access to complete
Software Development Team
60 people
Leadership Team
36 people
Senior Team
31 people
Legal and Compliance
15 people
Scientist Team
9 people
Product Management Team
8 people
Program Team
6 people
Principal Team
6 people
Unlock access to complete
Funding Insights of KBI Biopharma
KBI Biopharma has successfully raised a total of $18.29M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $9.6 million completed in August 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series A — $9.6M
-
First Round
First Round
(01 Apr 2003)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2009 | Amount | Series A - KBI Biopharma | Valuation |
investors |
|
| Feb, 2009 | Amount | Series A - KBI Biopharma | Valuation |
investors |
|
| Sep, 2008 | Amount | Unspecified - KBI Biopharma | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in KBI Biopharma
KBI Biopharma has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include NCBiotech, Ballast Point Ventures and INCJ. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Expansion capital is provided by Ballast Point Ventures to growing companies.
|
Founded Year | Domain | Location | |
|
Biotech startups are incubated and funded in North Carolina.
|
Founded Year | Domain | Location | |
|
Investment activities in various industries are conducted by INCJ.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by KBI Biopharma
KBI Biopharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Alliance Protein Laboratories. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Biophysical characterization services for proteins and macromolecules are provided.
|
1998 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - KBI Biopharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Kbi Biopharma Comparisons
Competitors of KBI Biopharma
KBI Biopharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aldevron, Kemwell Biopharma, Eurogentec, Ovagen and Laurus Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
|
|
| domain | founded_year | HQ Location |
Integrated biologics development and manufacturing are provided as a CDMO.
|
|
| domain | founded_year | HQ Location |
Oligonucleotides, peptides, and antibodies are developed and manufactured by Eurogentec.
|
|
| domain | founded_year | HQ Location |
Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services
|
|
| domain | founded_year | HQ Location |
Precision fermentation services for biopharma and food are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Kbi Biopharma
Frequently Asked Questions about KBI Biopharma
When was KBI Biopharma founded?
KBI Biopharma was founded in 1996 and raised its 1st funding round 7 years after it was founded.
Where is KBI Biopharma located?
KBI Biopharma is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Is KBI Biopharma a funded company?
KBI Biopharma is a funded company, having raised a total of $18.29M across 5 funding rounds to date. The company's 1st funding round was a Unspecified of $1.29M, raised on Apr 01, 2003.
How many employees does KBI Biopharma have?
As of Dec 31, 2021, the latest employee count at KBI Biopharma is 1,243.
What is the annual revenue of KBI Biopharma?
Annual revenue of KBI Biopharma is $31.68K as on Dec 31, 2023.
What does KBI Biopharma do?
KBI Biopharma was established in 1996 in Durham, United States, within the biopharmaceutical industry. Core operations encompass protein formulation, process and cell line development, alongside cGMP manufacturing services. These activities support biopharmaceutical clients from preclinical stages through to commercial-scale production. The company maintains its primary location in Durham, facilitating services across various global markets.
Who are the top competitors of KBI Biopharma?
KBI Biopharma's top competitors include Aldevron, Ovagen and Omnia Biologics.
What products or services does KBI Biopharma offer?
KBI Biopharma offers Cell Line Development, Process Development, Analytical Development, Formulation Development, and Clinical Manufacturing.
How many acquisitions has KBI Biopharma made?
KBI Biopharma has made 1 acquisition, including Alliance Protein Laboratories.
Who are KBI Biopharma's investors?
KBI Biopharma has 5 investors. Key investors include NCBiotech, Ballast Point Ventures, INCJ, CMiC, and JSR Life Sciences.